Learn more about our current products in the areas of the hips, knee, shoulder and our bone graft substitute synthetic. Ligamys is a new method of treatment to cruciate ligament preservation after rupture. Take a look in our comprehensive Portfolio or click through the corresponding product area.
Orthopaedists and medical specialists are one of our most important interest groups: The close cooperation in development and innovation projects with international users is one of the reasons why our products have been so successful worldwide.At specialist congresses we reach out to our international community by providing a platform for new innovations in our academy.
With more than 500 employees we are active worldwide as part of the movement: established in 1946 and active in the field of medical technology since 1958, we develop, produce and distribute products for artificial joint replacement, synthetic bone replacement material and for sports medicine. The families Mathys and Marzo own and manage the company with twelve subsidiaries in Europe and the Asian-Pacific region in 3rd generation.